Theratechnologies to Showcase Innovations at Key Investor Conferences
Theratechnologies Inc., a prominent biopharmaceutical company, is preparing to present at several important investor conferences. The Company’s President and CEO, Paul Lévesque, will lead discussions that emphasize their innovative therapies designed to meet critical medical needs. Additionally, the management team will be available for personal discussions with investors during these significant events.
H.C. Wainwright Annual Global Investment Conference
One of the major conferences where Theratechnologies will be participating is the H.C. Wainwright 26th Annual Global Investment Conference. This event presents a wonderful opportunity for investors to gain insights into the company's advancements and future plans.
Date and Presentation Details
The conference is scheduled to take place from September 9-11. Theratechnologies has organized a virtual presentation on the morning of September 9, allowing attendees from around the globe to engage with the Company’s insights.
Cantor Global Healthcare Conference
The 2024 Cantor Global Healthcare Conference is another significant event where Theratechnologies will showcase its presence. Investors will have the chance to receive firsthand insights from the Company regarding its recent initiatives.
Event Schedule
Taking place from September 17-19, the Cantor conference will feature a fireside chat with Paul Lévesque in the Empire Ballroom 1 on September 18, from 8:00-8:30 a.m. ET. This intimate setting will focus on Theratechnologies' strategic overview and future growth plans, making it a vital session for both current and potential investors.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is committed to developing and commercializing innovative therapies that address unmet medical needs. The Company’s dedication to cutting-edge research and development is evident through its progressive pipeline of treatments.
Commitment to Innovation
With a focus on improving the quality of life through groundbreaking therapies, Theratechnologies is determined to tackle significant healthcare challenges. Their ongoing research efforts aim to deliver solutions that empower patients and redefine treatment standards.
Connecting with Investors
The Company is eager to build strong relationships with investors. Theratechnologies encourages interested parties to learn more about their initiatives through the upcoming events and presentations.
Contact Information
For any inquiries, investors are welcome to reach out via email. Philippe Dubuc, the Senior Vice President and Chief Financial Officer, is available for investor-related questions at pdubuc@theratech.com. Media inquiries can be directed to Julie Schneiderman at communications@theratech.com. With a commitment to transparency and communication, Theratechnologies ensures that stakeholders have access to relevant information.
Frequently Asked Questions
What is the main focus of Theratechnologies?
Theratechnologies is dedicated to developing innovative biopharmaceutical therapies that address unmet medical needs.
When will Theratechnologies present at the H.C. Wainwright Conference?
The virtual presentation is scheduled for the morning of September 9, 2024.
Where can I find more information about Theratechnologies?
Additional information about the company can be found on their official website and SEDAR+.
Who is the CEO of Theratechnologies?
Paul Lévesque serves as the President and CEO of Theratechnologies.
How can I reach the investor relations team?
Investors can contact Philippe Dubuc at pdubuc@theratech.com for inquiries related to investments.
